Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib.

Annals of oncology : official journal of the European Society for Medical Oncology - 1 Aug 2014

Zhang L, Li Q X, Wu H L, Lu X, Yang M, Yu S Y, Yuan X L

Abstract excerpt

BACKGROUND: The aim of this study was to evaluate whether genetic variations in the transforming growth factor-β (TGF-β) pathway influenced clinical outcome of advanced lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations treated with gefitinib. PATIENTS AND METHODS: Two hun...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Quinazolines

Share to Smad3 Protein

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 24928833
DOI: 10.1093/annonc/mdu172

Genes

EGFR
SMAD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24928833-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SNPs in the transforming growth factor-β pathway as predictors of outcome in advanced lung adenocarcinoma with EGFR mutations treated with gefitinib.PMID 24928833Read ↗

Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.Semantic proximity Read ↗

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.Semantic proximity Read ↗

Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk.Semantic proximity Read ↗

Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.Semantic proximity Read ↗

Polymorphisms in genes related to epithelial-mesenchymal transition and risk of non-small cell lung cancer.Semantic proximity Read ↗

Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis.Semantic proximity Read ↗

TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.Semantic proximity Read ↗

TGFβ1 Genetic Variants Predict Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.Semantic proximity Read ↗

Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.Semantic proximity Read ↗

Association between single nucleotide polymorphisms of the transforming growth factor-β1 gene and overall survival in unresectable locally advanced non-small-cell lung cancer patients treated with radio(chemo)therapy in a Chinese population.Semantic proximity Read ↗

EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.Semantic proximity Read ↗

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.